These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17092716)

  • 1. Synthesis and evaluation of peptidic maleimides as transglutaminase inhibitors.
    Halim D; Caron K; Keillor JW
    Bioorg Med Chem Lett; 2007 Jan; 17(2):305-8. PubMed ID: 17092716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of peptidic irreversible inhibitors of tissue transglutaminase.
    Pardin C; Gillet SM; Keillor JW
    Bioorg Med Chem; 2006 Dec; 14(24):8379-85. PubMed ID: 17008102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible and competitive cinnamoyl triazole inhibitors of tissue transglutaminase.
    Pardin C; Roy I; Lubell WD; Keillor JW
    Chem Biol Drug Des; 2008 Sep; 72(3):189-96. PubMed ID: 18715232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue transglutaminase inhibition.
    Keillor JW
    Chem Biol; 2005 Apr; 12(4):410-2. PubMed ID: 15850975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of novel dipeptide-bound 1,2,4-thiadiazoles as irreversible inhibitors of guinea pig liver transglutaminase.
    Marrano C; de Macédo P; Gagnon P; Lapierre D; Gravel C; Keillor JW
    Bioorg Med Chem; 2001 Dec; 9(12):3231-41. PubMed ID: 11711299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sensitive fluorometric assay for tissue transglutaminase.
    Jeitner TM; Fuchsbauer HL; Blass JP; Cooper AJ
    Anal Biochem; 2001 May; 292(2):198-206. PubMed ID: 11355851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 3: Importance of the indole orientation.
    Lu Q; Chen Z; Perumattam J; Wang DX; Liang W; Xu YJ; Do S; Bonaga L; Higaki J; Dong H; Liclican A; Sideris S; Laney M; Dugar S; Mavunkel B; Levy DE
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2399-403. PubMed ID: 18337095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 1: SAR of the aryl region.
    Levy DE; Wang DX; Lu Q; Chen Z; Perumattam J; Xu YJ; Liclican A; Higaki J; Dong H; Laney M; Mavunkel B; Dugar S
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2390-4. PubMed ID: 18334294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photolabeling of tissue transglutaminase reveals the binding mode of potent cinnamoyl inhibitors.
    Pardin C; Roy I; Chica RA; Bonneil E; Thibault P; Lubell WD; Pelletier JN; Keillor JW
    Biochemistry; 2009 Apr; 48(15):3346-53. PubMed ID: 19271761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 2: SAR of the amine tether.
    Levy DE; Wang DX; Lu Q; Chen Z; Perumattam J; Xu YJ; Higaki J; Dong H; Liclican A; Laney M; Mavunkel B; Dugar S
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2395-8. PubMed ID: 18334295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cinnamoyl inhibitors of tissue transglutaminase.
    Pardin C; Pelletier JN; Lubell WD; Keillor JW
    J Org Chem; 2008 Aug; 73(15):5766-75. PubMed ID: 18582115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of novel dipeptide-bound alpha,beta-unsaturated amides and epoxides as irreversible inhibitors of guinea pig liver transglutaminase.
    Marrano C; de Macédo P; Keillor JW
    Bioorg Med Chem; 2001 Jul; 9(7):1923-8. PubMed ID: 11425595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of the interaction of tissue transglutaminase with a nonpeptidic slow-binding inhibitor.
    Case A; Stein RL
    Biochemistry; 2007 Jan; 46(4):1106-15. PubMed ID: 17240993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship study of novel tissue transglutaminase inhibitors.
    Duval E; Case A; Stein RL; Cuny GD
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1885-9. PubMed ID: 15780627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New protein reagents. Synthesis and properties of halogenated maleimides and isomaleimides.
    Lautié JP; Olomucki M
    Hoppe Seylers Z Physiol Chem; 1978 Feb; 359(2):211-8. PubMed ID: 649055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors.
    Badarau E; Mongeot A; Collighan R; Rathbone D; Griffin M
    Eur J Med Chem; 2013 Aug; 66():526-30. PubMed ID: 23835447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid-phase synthesis and pharmacological evaluation of a library of peptidomimetics as potential farnesyltransferase inhibitors: an approach to new lead compounds.
    Gilleron P; Millet R; Houssin R; Wlodarczyk N; Farce A; Lemoine A; Goossens JF; Chavatte P; Pommery N; Hénichart JP
    Eur J Med Chem; 2006 Jun; 41(6):745-55. PubMed ID: 16647166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescent probes of tissue transglutaminase reveal its association with arterial stiffening.
    Chabot N; Moreau S; Mulani A; Moreau P; Keillor JW
    Chem Biol; 2010 Oct; 17(10):1143-50. PubMed ID: 21035737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis.
    Sohn J; Kim TI; Yoon YH; Kim JY; Kim SY
    J Clin Invest; 2003 Jan; 111(1):121-8. PubMed ID: 12511595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient synthesis of maleimides and carbazoles via Zn(OTf)(2)-catalyzed tandem annulations of isonitriles and allenic esters.
    Li Y; Zou H; Gong J; Xiang J; Luo T; Quan J; Wang G; Yang Z
    Org Lett; 2007 Sep; 9(20):4057-60. PubMed ID: 17725362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.